However, contradictory results have been described when the concentration of CX3CL1 was measured in cerebrospinal fluid samples obtained from patients suffering from mild cognitive impairment or Alzheimer’s disease. Here, CX3CL1 is linked to early-onset autosomal dominant Alzheimer disease.